Transpact Enterprises Limited IPO

Apply 0
Avoid 0

(i) The company was incorporated on May 12, 2013, as ‘Transpact Enterprises Private Limited’ under the provisions of Companies Act, 1956 with the Registrar of Companies, Mumbai at Maharashtra.

(ii) They are a MedTech startUp with a focus to provide innovative, cost-effective and comprehensive solutions, products with strategic partnerships and collaborative relationships to help especially abled people to transcend their barriers. The Company is registered as a startUp with MSME/DIPP bearing certificate No. DIPP3317.

(iii) They have designed and developed a therapeutic device – ‘Vestibulator’ which is a unique and innovative therapeutic design in medical device segment.

Vestibulator has been incubated at SINE (Society for Innovation and Entrepreneurship), IIT Bombay. Further, a license agreement had been executed between IIT Bombay and our company to carry out all commercialization activities.

The company along with IIT Bombay has filed a joint patent for the technology of Vestibulator with Controller General of Patents, Designs, and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry.

Vestibulator is a compact, mechanized, innovative therapeutic device which is ergonomically designed to provide stimulations for vestibular, neurodevelopmental and sensory integration therapy

(iv) They have given a contract to the third party to manufacture Vestibulator which they sell in the market. The Company aiming at partnering with hospitals therapy centers, rehabilitation center, and special children school for the installation of the product.

Transpact Enterprises Limited IPO Stock Quote & Charts



  • Open: 132.00
  • High - Low: 132.00 - 132.00
  • Previous Close: 132.00
  • Total Traded Volume: 4000
  • Updated On: 31-Jan-2020

Objects of the Transpact Enterprises Limited IPO:

The Objects of the Net Issue is to raise funds for: (a) Redemption of Preference Shares (b) Acquisition of R & D facility and Registered Office on a long term basis (c) General Corporate Purpose

Transpact Enterprises Limited IPO Details:

Open Date: Aug 26 2019
Close Date: Aug 28 2019
Total Shares: 104000
Face Value: ₹ 10 Per Equity Share
Issue Type: fixed price
Issue Size: 1.35 Cr.
Lot Size: 1000 Shares
Issue Price: ₹ 130 Per Equity Share
Listing At: BSE SME
Listing Date: Sep 05 2019

Promoters And Management:

The Company is promoted by Mr. Aslam Khan and Mr. Anis Choudhery. The promoter Mr. Aslam Khan has entrepreneurial experience in Information Technology and Healthcare industry. The other promoter Mr. Anis Choudhery is a social worker, entrepreneur, and management guru.

Financials of Transpact Enterprises Limited IPO:

Particulars in lakh 31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16
Total Revenue 13 - - -
PAT -7.1 -9.15 -4.53 -7.06
The company has a total Revenue of 13 lakh with a loss of 7.1 Lakh. The company is issuing shares at a market cap of 5.02 Cr. The valuation looks very expensive.

Comparison With Peers:

No peer in the market to compare with.

Recommendation on Transpact Enterprises Limited IPO:

Review and Recommendation of InvestorZone is:  2/10 The company is still not have started making a profit. They have recently commercialized the device and we do not know how well the product will do in the market. The IPO pricing is also done at very high valuations. One of the objectives of the company is the redemption of preference shares worth Rs. 28.65 Lakh which looks quite funny. How come you raise money from the market to pay off other investors money?

Lead Manager of Transpact Enterprises Limited IPO:

  1. Aryaman Financial Services Limited

Registrar of Transpact Enterprises Limited IPO:

  1. Bigshare Services Private Limited

Bid Details of Transpact Enterprises Limited IPO as on
28 Aug 2019 | 11:55:02 PM

Category No.of shares offered No. of shares bid
49,000 44,000
49,000 67,000
6,000 6,000
104,000 117,000
QIBs+HNIs Subscription 0.90X
Retail Subscription 1.37X
Total Subscription 1.13X

Discussion on Transpact Enterprises Limited IPO:

Leave a Reply